Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nickel Catalyzed Reductive Cyclization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115010575B details a novel nickel-catalyzed route for 2-trifluoromethylnaphthalene derivatives, offering mild conditions and high yields for reliable pharmaceutical intermediate supply.
Patent CN109293700B discloses a novel chiral ligand enabling ultra-low nickel loading for enantioselective cyclization, offering significant cost and efficiency advantages.